✦ LIBER ✦

Long-term Safety of Pioglitazone versus Glyburide in Patients with Recently Diagnosed Type 2 Diabetes Mellitus

✍ Scribed by Dr. Rajeev Jain; Dr. Kwame Osei; Dr. Stuart Kupfer; Dr. Alfonso T. Perez; Mr. Jeff Zhang; Mary-Margaret Lannon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term pioglitazone therapy improves

✍ Keiichiro Harashima; Junichi Hayashi; Takashi Miwa; Tooru Tsunoda 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 492 KB

Hypoglycemic potential of nateglinide ve

✍ V.A. Fonseca; D.E. Kelley; W. Cefalu; M.A. Baron; D. Purkayastha; J.E. Nestler; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Long-term glycaemic control with pioglit

✍ I.W. Campbell 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Withdrawal of pioglitazone in patients w

✍ M. Iwase; T. Asano; N. Sasaki; H. Yoshizumi; S. Hiramatsu; Y. Sakai; A. Ogo; M. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Long-term effects of pioglitazone and me

✍ M. Roden; M. Laakso; D. Johns; M. Widel; R. Urquhart; C. Richardson; S. Mariz; M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Durability of efficacy and long-term saf

✍ Alan J. Garber; Simon Bruce; Fred T. Fiedorek 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 869 KB